Phase II Study of Tesetaxel in Metastatic Melanoma

NCT01064713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma
Cancer

Interventions

DRUG: Tesetaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]